医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

In Silico Analysis of the Ability of Tecomella undulata to Treat Parkinson’s Disease: Unveiling the Potential of Natural Drug Design, Development, and Therapy

In Silico Analysis of the Ability of Tecomella undulata to Treat Parkinson’s Disease: Unveiling the Potential of Natural Drug Design, Development, and Therapy

摘要Monoamine oxidase (MAO) is an enzyme that plays a crucial role in breaking down monoamine neurotransmitters, including serotonin, dopamine, and norepinephrine, thereby regulating their levels in the brain and other tissues. A decrease in MAO enzymes leads to a nonfatal neurological condition that can lead to Parkinson’s disease. In this study, compounds from Tecomella undulata that mimic the structure of MAO-A can be used as substitutes for the blood-brain barrier, which was confirmed via in silico approaches. To study protein-ligand interactions, the target protein, MAO-A (Protein Data Bank ID: 2Z5Y), was subjected to molecular docking and dynamics studies with high-affinity compounds extracted from T. undulata. Among the 30 phytochemicals that were subjected to molecular docking simulation to examine the behavior of the dynamic protein complex, the compounds with the highest binding affinities were squalene, benzoic acid, 4-methyl-[4-(methoxycarbonyl)phenyl] methyl ester, and stigmasterol. In terms of the root mean square deviation (RMSD), root mean square fluctuation, ligand RMSD, radius of gyration, solvent accessible surface area, and H bond, ligand binding demonstrated sustained stability throughout the simulation period. The results suggest that substances derived from T. undulata show important potential for treating Parkinson’s disease, justifying additional research through both in vitro and in vivo experiments.

更多

abstractsMonoamine oxidase (MAO) is an enzyme that plays a crucial role in breaking down monoamine neurotransmitters, including serotonin, dopamine, and norepinephrine, thereby regulating their levels in the brain and other tissues. A decrease in MAO enzymes leads to a nonfatal neurological condition that can lead to Parkinson’s disease. In this study, compounds from Tecomella undulata that mimic the structure of MAO-A can be used as substitutes for the blood-brain barrier, which was confirmed via in silico approaches. To study protein-ligand interactions, the target protein, MAO-A (Protein Data Bank ID: 2Z5Y), was subjected to molecular docking and dynamics studies with high-affinity compounds extracted from T. undulata. Among the 30 phytochemicals that were subjected to molecular docking simulation to examine the behavior of the dynamic protein complex, the compounds with the highest binding affinities were squalene, benzoic acid, 4-methyl-[4-(methoxycarbonyl)phenyl] methyl ester, and stigmasterol. In terms of the root mean square deviation (RMSD), root mean square fluctuation, ligand RMSD, radius of gyration, solvent accessible surface area, and H bond, ligand binding demonstrated sustained stability throughout the simulation period. The results suggest that substances derived from T. undulata show important potential for treating Parkinson’s disease, justifying additional research through both in vitro and in vivo experiments.

More
广告
  • 浏览1
  • 下载0
生物组学研究杂志(英文)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷